You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨創新藥概念股強勢 一品紅20cm升停創歷史新高
格隆匯 04-14 11:15

A股創新藥概念股表現強勢,一品紅、悦康藥業錄得20cm升停,其中一品紅股價創歷史新高並且錄得連續2日升停,科興製藥、廣生堂升超14%,東誠藥業、奧賽康、舒泰神、亞虹醫藥皆升超7.5%以上。消息面上,興業證券報吿認為,近期,創新藥領域催化劑不斷,包括海外授權、國內政策和臨牀數據進展等。預計和去年相比今年國產創新藥重要數據將較多,有望為創新藥板塊帶來正面催化。中信建投提出,看好暫不受關税影響的創新藥行業。另外,天風證券指出,一品紅創新研發聚焦痛風領域,有望迎來收穫期。看好公司進入加速發展階段,給予公司2025年8倍PS,對應目標價35.88元,首次覆蓋,給予“買入”評級。(格隆匯)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account